Skip to main content
Home
  • Catalog
  • Online payment
  • Join us
  • My Cerba
  • FR
  • About us

    Cerba is a leading reference in specialised medical biology in France and internationally. For over 50 years, it has been leveraging its medical expertise and strong capacity for innovation to serve patients, healthcare professionals, and the pharmaceutical industry.

    • Cerba, leader in specialised clinical pathology
    • Our governance
    • Our missions
    • Our innovations
    • Clinical research projects
    • Our CSR policy
    • Our quality commitments
    • Our values
    • Cerba HealthCare group
  • Our expertise

    Since 1967, Cerba has been leveraging its expertise and innovation to serve healthcare. Recognized in France and internationally, our laboratory is a leading player in specialised medical biology, offering a high level of excellence for patients and healthcare professionals.

    • Allergology
    • Autoimmunity
    • Specialized biochemistry
    • Genetics and cytogenetics
    • Hematology
    • Infectiology
    • Oncology
    • Onco-hematology
    • Pharmacology
    • Toxicology
    • Clinical trial biology
  • Training and resources

    We are committed daily to placing medical biology at the heart of the care pathway to improve patient management in terms of prevention, diagnosis, and monitoring of diseases. This involves medical and technical expertise, innovation, as well as a range of training programs and a constantly evolving array of services and tools.

    • Certified Scientific Training Programs
    • Cerba Live Sessions
    • Podcast - Biomedically Yours
    • My Cerba portal
    • Customer care - practical tutorials
    • Cerba Flash - the connected prescription
    • The journey of a sample
    • FAQ
  • Our news
  • Contact us
  • Catalog
  • Online payment
  • Join us
  • My Cerba
  • Evénements

Evénements

article categories

Tous nos articles

  • CERTIFICATION TRAINING
  • FORMATION CERTIFIANTE
  • CLS#74 Kappa Index: A New Biomarker in the Diagnosis of Multiple Sclerosis (MS)
  • CLS#74 L’index Kappa : un nouveau biomarqueur dans le diagnostic de la Sclérose en Plaque (SEP)
  • [PODCAST] Edition spéciale Innovation médicale
  • CLS#68 DPD - Julien Bourgain
  • [Podcast S4 E5] Bilan lithiasique : quelles étapes pour un diagnostic complet ?
  • CLS67 Place et intérêts de la cytogénétique dans la prise en charge des hémopathies malignes - Claire Bracquemart
  • RICAI 2024 : les communications médicales Cerba
About us
  • Cerba, leader in specialized clinical pathology
  • Our governance
  • Our missions
  • Our innovations
  • Clinical research projects
  • Our CSR policy
  • Our quality commitments
  • Our values
  • Cerba HealthCare group
Our expertise
  • Allergology
  • Autoimmunity
  • Specialised biochemistry
  • Genetics and cytogenetics
  • Hematology
  • Infectiology
  • Oncology
  • Onco-hematology
  • Pharmacology
  • Toxicology
  • Clinical trial biology
Training and resources
  • Certified Scientific Training Programs
  • Cerba Live Session
  • Podcast - Biomedically Yours
  • My Cerba portal
  • Customer care - practical tutorials
  • Cerba Flash - the connected prescription
  • The journey of a sample
  • FAQ
  • Historique des documents
  • Mentions Légales
  • Politique de protection des données
© Lab Cerba